Biosynex Stock
Stocks
ALBIO
FR0011005933
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time
Euronext Paris
06:53:49 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.8240 EUR | -1.67% |
|
-11.40% | +38.26% |
| 09-04 | Biosynex: creditors to vote on financial safeguard plan |  |
| 08-06 | Biosynex hit by cyberattack, operational activity remains intact | |
| Market Cap | 15.45M 17.39M 14.44M 13.16M 24.78M 1.67B 25.12M 175M 67.65M 853M 65.29M 63.88M 2.74B | P/E 2024 |
-0.43x | P/E 2025 | -0.19x |
|---|---|---|---|---|---|
| Enterprise Value | 68.64M 77.28M 64.19M 58.49M 110M 7.44B 112M 777M 301M 3.79B 290M 284M 12.17B | EV / Sales 2024 |
0.71x | EV / Sales 2025 | 0.68x |
| Free-Float |
40.35% | Yield 2024 * |
-
| Yield 2025 | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALBIO | Real-time | |
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| 0DL | Delayed | |
|
Börse Stuttgart
| 0DL | Delayed | |
|
Boerse Muenchen
| 0DL | Real-time | |
|
CBOE
| Real-time |
| 1 day | -1.67% | ||
| 1 week | -11.40% | ||
| Current month | -5.72% | ||
| 1 month | -6.36% | ||
| 3 months | -8.85% | ||
| 6 months | +7.01% | ||
| Current year | +38.26% |
| 1 week | 0.81 |  | 0.97 |
| 1 month | 0.81 | | 1.06 |
| Current year | 0.56 | | 1.57 |
| 1 year | 0.46 | | 1.57 |
| 3 years | 0.46 | | 9.97 |
| 5 years | 0.46 | | 28.78 |
| 10 years | 0.46 | | 30.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Larry Abensur
CEO | Chief Executive Officer | 71 | 2015-06-23 |
Thierry Paper
CTO | Chief Tech/Sci/R&D Officer | 63 | 2014-12-31 |
Oren Bitton
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Paper
BRD | Director/Board Member | 63 | 2015-06-23 |
Thomas Lamy
BRD | Director/Board Member | - | 2015-06-23 |
Larry Abensur
CHM | Chairman | 71 | 2015-06-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/15/23 | Buy | Director | 2,500 | 0.0244% | ||
| 2/15/23 | Buy | Director | 2,500 | 0.0244% | ||
| 2/28/22 | Buy | Chief Executive Officer | 2,000 | 0.0180% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.67% | -11.40% | +20.12% | -91.57% | 17.39M | |
| -2.17% | -4.33% | -27.56% | -0.17% | 167B | |
| +0.17% | -2.34% | -8.83% | +10.31% | 111B | |
| -0.88% | +1.19% | -25.04% | -0.11% | 105B | |
| +0.59% | +1.01% | -48.13% | -11.19% | 74.82B | |
| +3.17% | -0.03% | -0.64% | +72.13% | 59.11B | |
| -0.86% | +2.96% | +13.57% | +59.50% | 51.8B | |
| -0.52% | -0.65% | -6.74% | -31.12% | 48.5B | |
| -0.85% | +0.85% | -16.51% | +18.41% | 40.79B | |
| -0.07% | -1.42% | +30.49% | -7.58% | 32.54B | |
| Average | -0.30% | -0.77% | -6.93% | +1.86% | 69.02B | |
| Weighted average by Cap. | -0.44% | -0.91% | -16.16% | +9.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 101M 114M 94.61M 86.21M 162M 10.97B 165M 1.14B 443M 5.59B 428M 418M 17.94B | 95.19M 107M 89.02M 81.12M 153M 10.32B 155M 1.08B 417M 5.26B 402M 394M 16.88B |
| Net income | -43.33M -48.79M -40.52M -36.93M -69.52M -4.7B -70.48M -490M -190M -2.39B -183M -179M -7.68B | -58.22M -65.55M -54.45M -49.62M -93.41M -6.31B -94.7M -659M -255M -3.21B -246M -241M -10.32B |
| Net Debt | 52.94M 59.6M 49.5M 45.11M 84.93M 5.74B 86.1M 599M 232M 2.92B 224M 219M 9.39B | 53.19M 59.89M 49.74M 45.33M 85.34M 5.77B 86.51M 602M 233M 2.94B 225M 220M 9.43B |
Employees
397
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | €0.8240 | -1.67% | 10,705 |
| 26-10-01 | €0.8380 | -4.12% | 21,592 |
| 26-09-30 | €0.8740 | -2.02% | 23,314 |
| 26-09-29 | €0.8920 | -0.22% | 10,528 |
| 26-09-28 | €0.8940 | -3.87% | 22,154 |
- Stock Market
- Stocks
- ALBIO Stock
Select your edition
All financial news and data tailored to specific country editions
